IBDEI0K9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9418,0)
 ;;=H34.233^^41^478^70
 ;;^UTILITY(U,$J,358.3,9418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9418,1,3,0)
 ;;=3^Retinal Artery Branch Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,9418,1,4,0)
 ;;=4^H34.233
 ;;^UTILITY(U,$J,358.3,9418,2)
 ;;=^5005566
 ;;^UTILITY(U,$J,358.3,9419,0)
 ;;=H34.211^^41^478^63
 ;;^UTILITY(U,$J,358.3,9419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9419,1,3,0)
 ;;=3^Partial Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,9419,1,4,0)
 ;;=4^H34.211
 ;;^UTILITY(U,$J,358.3,9419,2)
 ;;=^5005560
 ;;^UTILITY(U,$J,358.3,9420,0)
 ;;=H34.212^^41^478^62
 ;;^UTILITY(U,$J,358.3,9420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9420,1,3,0)
 ;;=3^Partial Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,9420,1,4,0)
 ;;=4^H34.212
 ;;^UTILITY(U,$J,358.3,9420,2)
 ;;=^5005561
 ;;^UTILITY(U,$J,358.3,9421,0)
 ;;=H34.213^^41^478^61
 ;;^UTILITY(U,$J,358.3,9421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9421,1,3,0)
 ;;=3^Partial Retinal Artery Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,9421,1,4,0)
 ;;=4^H34.213
 ;;^UTILITY(U,$J,358.3,9421,2)
 ;;=^5005562
 ;;^UTILITY(U,$J,358.3,9422,0)
 ;;=H34.811^^41^478^11
 ;;^UTILITY(U,$J,358.3,9422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9422,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,9422,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,9422,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,9423,0)
 ;;=H34.813^^41^478^9
 ;;^UTILITY(U,$J,358.3,9423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9423,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,9423,1,4,0)
 ;;=4^H34.813
 ;;^UTILITY(U,$J,358.3,9423,2)
 ;;=^5005570
 ;;^UTILITY(U,$J,358.3,9424,0)
 ;;=H34.831^^41^478^108
 ;;^UTILITY(U,$J,358.3,9424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9424,1,3,0)
 ;;=3^Tributary Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,9424,1,4,0)
 ;;=4^H34.831
 ;;^UTILITY(U,$J,358.3,9424,2)
 ;;=^5005576
 ;;^UTILITY(U,$J,358.3,9425,0)
 ;;=H34.832^^41^478^107
 ;;^UTILITY(U,$J,358.3,9425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9425,1,3,0)
 ;;=3^Tributary Retinal Vein Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,9425,1,4,0)
 ;;=4^H34.832
 ;;^UTILITY(U,$J,358.3,9425,2)
 ;;=^5005577
 ;;^UTILITY(U,$J,358.3,9426,0)
 ;;=H34.833^^41^478^106
 ;;^UTILITY(U,$J,358.3,9426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9426,1,3,0)
 ;;=3^Tributary Retinal Vein Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,9426,1,4,0)
 ;;=4^H34.833
 ;;^UTILITY(U,$J,358.3,9426,2)
 ;;=^5005578
 ;;^UTILITY(U,$J,358.3,9427,0)
 ;;=H35.711^^41^478^14
 ;;^UTILITY(U,$J,358.3,9427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9427,1,3,0)
 ;;=3^Central Serouos Chorioretinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,9427,1,4,0)
 ;;=4^H35.711
 ;;^UTILITY(U,$J,358.3,9427,2)
 ;;=^5005703
 ;;^UTILITY(U,$J,358.3,9428,0)
 ;;=H35.712^^41^478^13
 ;;^UTILITY(U,$J,358.3,9428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9428,1,3,0)
 ;;=3^Central Serouos Chorioretinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,9428,1,4,0)
 ;;=4^H35.712
 ;;^UTILITY(U,$J,358.3,9428,2)
 ;;=^5005704
 ;;^UTILITY(U,$J,358.3,9429,0)
 ;;=H35.713^^41^478^12
 ;;^UTILITY(U,$J,358.3,9429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9429,1,3,0)
 ;;=3^Central Serouos Chorioretinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,9429,1,4,0)
 ;;=4^H35.713
 ;;^UTILITY(U,$J,358.3,9429,2)
 ;;=^5005705
 ;;^UTILITY(U,$J,358.3,9430,0)
 ;;=H35.721^^41^478^98
 ;;^UTILITY(U,$J,358.3,9430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9430,1,3,0)
 ;;=3^Serous Detachment of Retinal Pigment Epithelium,Right Eye
